Nikas IP - Search Results

1

Immune marker expression and prognosis of early breast cancer expressing HER3.

Lee DW, Ryu HS, Nikas IP, Koh J, Kim TY, Kim HK, Lee HB, Moon HG, Han W, Lee KH, Im SA. Lee DW, et al. Among authors: nikas ip. Eur J Cancer. 2024 Dec;213:115081. doi: 10.1016/j.ejca.2024.115081. Epub 2024 Oct 20. Eur J Cancer. 2024. PMID: 39447449

2

Viewing the Eph receptors with a focus on breast cancer heterogeneity.

Nikas I, Ryu HS, Theocharis S. Nikas I, et al. Cancer Lett. 2018 Oct 10;434:160-171. doi: 10.1016/j.canlet.2018.07.030. Epub 2018 Jul 25. Cancer Lett. 2018. PMID: 30055288 Review.

3

Biomarkers expression among paired serous ovarian cancer primary lesions and their peritoneal cavity metastases in treatment-naïve patients: A single-center study.

Nikas IP, Lee C, Song MJ, Kim B, Ryu HS. Nikas IP, et al. Cancer Med. 2022 Jun;11(11):2193-2203. doi: 10.1002/cam4.4600. Epub 2022 Feb 25. Cancer Med. 2022. PMID: 35212471 Free PMC article.

4

The application of high-throughput proteomics in cytopathology.

Nikas IP, Ryu HS. Nikas IP, et al. J Pathol Transl Med. 2022 Nov;56(6):309-318. doi: 10.4132/jptm.2022.08.30. Epub 2022 Nov 9. J Pathol Transl Med. 2022. PMID: 36345621 Free PMC article. Review.

5

The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer.

Choi JE, Lee JS, Jin MS, Nikas IP, Kim K, Yang S, Park SY, Koh J, Yang S, Im SA, Ryu HS. Choi JE, et al. Among authors: nikas ip. Breast Cancer Res. 2023 Nov 3;25(1):134. doi: 10.1186/s13058-023-01710-8. Breast Cancer Res. 2023. PMID: 37924153 Free PMC article.

6

Quantitative proteomics identifies TUBB6 as a biomarker of muscle-invasion and poor prognosis in bladder cancer.

Kim B, Jung M, Moon KC, Han D, Kim K, Kim H, Yang S, Lee D, Jun H, Lee KM, Lee CH, Nikas IP, Yang S, Lee H, Ryu HS. Kim B, et al. Among authors: nikas ip. Int J Cancer. 2023 Jan 15;152(2):320-330. doi: 10.1002/ijc.34265. Epub 2022 Sep 10. Int J Cancer. 2023. PMID: 36054443

7

Clinical application of the anti-human telomerase reverse transcriptase (hTERT) antibody (SCD-A7) immunocytochemistry in liquid-based urine cytology: A prospective, single institute study.

Moon JH, Nikas IP, Moon KC, Kim B, Ryu HS. Moon JH, et al. Among authors: nikas ip. Cancer Med. 2023 May;12(9):10363-10370. doi: 10.1002/cam4.5767. Epub 2023 Mar 14. Cancer Med. 2023. PMID: 36916414 Free PMC article.

8

Expression of EGFR, PD-L1, and the mismatch repair proteins before and following therapy in malignant serous effusions with metastatic high-grade serous tubo-ovarian carcinoma.

Nikas IP, Park SY, Song MJ, Lee C, Ryu HS. Nikas IP, et al. Diagn Cytopathol. 2024 Feb;52(2):69-75. doi: 10.1002/dc.25248. Epub 2023 Nov 8. Diagn Cytopathol. 2024. PMID: 37937321

9

The Role of Nicotinamide in Cancer Chemoprevention and Therapy.

Nikas IP, Paschou SA, Ryu HS. Nikas IP, et al. Biomolecules. 2020 Mar 20;10(3):477. doi: 10.3390/biom10030477. Biomolecules. 2020. PMID: 32245130 Free PMC article. Review.

10

Diagnostic distribution and pitfalls of glandular abnormalities in cervical cytology: a 25-year single-center study.

Sung JA, Nikas IP, Kim H, Ryu HS, Lee C. Sung JA, et al. Among authors: nikas ip. J Pathol Transl Med. 2022 Nov;56(6):354-360. doi: 10.4132/jptm.2022.09.05. Epub 2022 Nov 9. J Pathol Transl Med. 2022. PMID: 36345619 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters